Serious musculoskeletal infections in children receiving anti-tumor necrosis factor-alpha therapy: a case series.
Anti-tumor necrosis factor-alpha (anti-TNF-alpha) agents are widely used to treat children with juvenile idiopathic arthritis (JIA) whose disease is resistant to conventional therapy. Although generally well tolerated, use of these agents has been associated with an increased risk of infection. In particular, in patients treated with anti-TNF-alpha agents, there is an increased susceptibility to infection by intracellular organisms such as tuberculosis, and common infections may present atypically or be more severe. We report four cases of serious musculoskeletal infections among 31 children with JIA being treated with anti-TNF-alpha agents, two of which were secondary to group A beta-hemolytic Streptococcus.
Morishita
Kimberly
K
Division of Rheumatology, British Columbia's Children's Hospital, University of British Columbia, Vancouver, BC V6H 3V4, Canada. kmorishita@cw.bc.ca
Petty
Ross
R
Cairns
Robyn
R
Bolaria
Roxana
R
Cabral
David
D
Turvey
Stuart
S
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects; D001171:Arthritis, Juvenile / Q000276:immunology / Q000628:therapy*; D001424:Bacterial Infections / Q000139:chemically induced* / Q000276:immunology; D002675:Child, Preschool; D005260:Female; D006801:Humans; D000069285:Infliximab; D009140:Musculoskeletal Diseases / Q000139:chemically induced* / Q000276:immunology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab
Rheumatology (Oxford). 2004 Apr;43(4):527-9
15024141
N Engl J Med. 2008 Aug 21;359(8):810-20
18716298
Medicine (Baltimore). 2005 Sep;84(5):291-302
16148729
Clin Microbiol Rev. 2009 Apr;22(2):274-90, Table of Contents
19366915
Rheumatology (Oxford). 2003 Dec;42(12):1564-5
14645859
Arthritis Rheum. 2003 Aug;48(8):2122-7
12905464
N Engl J Med. 2000 Nov 30;343(22):1594-602
11096166
Rheumatology (Oxford). 2009 Aug;48(8):978-86
19535611
Clin Orthop Relat Res. 2004 Jan;(418):219-21
15043120
Semin Arthritis Rheum. 2003 Aug;33(1):1-18
12920692
Arthritis Rheum. 2003 Jan;48(1):218-26
12528122
J Pediatr Orthop. 1996 Jul-Aug;16(4):522-8
8784712
J Rheumatol. 2006 Apr;33(4):825; author reply 826-7
16583487
Paediatr Drugs. 2004;6(3):137-46
15170361
JAMA. 2006 May 17;295(19):2275-85
16705109
Clin Infect Dis. 2004 May 1;38(9):1261-5
15127338
Pediatr Infect Dis J. 2003 Mar;22(3):286-8
12664882
Ann Rheum Dis. 2009 Apr;68(4):519-25
18413440
Pediatrics. 1972 Sep;50(3):437-40
4403468
Am J Respir Crit Care Med. 2003 May 1;167(9):1279-82
12615627
Ann Rheum Dis. 2003 Dec;62(12):1168-77
14644854
Ann Rheum Dis. 2009 Jul;68(7):1136-45
18753157
Best Pract Res Clin Rheumatol. 2006 Dec;20(6):1181-95
17127203
Arthritis Rheum. 2007 Sep;56(9):3096-106
17763439
N Engl J Med. 2000 Mar 16;342(11):763-9
10717011
Lancet Infect Dis. 2003 Mar;3(3):148-55
12614731
N Engl J Med. 2002 Feb 21;346(8):623-6
11859881
J Rheumatol. 2003 Dec;30(12):2563-71
14719195
Rheumatology (Oxford). 2003 May;42(5):617-21
12709536
Clin Pediatr (Phila). 1999 Aug;38(8):481-3
10456244